Table 3.
Validation of highly upregulated or downregulated genes using real-time quantitative PCR.
| Gene | RT-qPCR | RNA-Seq | ||
|---|---|---|---|---|
| Fold change (FF vs NF) | p value | Fold change (FF vs NF) | p value | |
| MYOCD | +30.22** | 0.005 | +11.45** | 0.006 |
| LMO3 | +7.11* | 0.046 | +9.13** | 0.003 |
| IL-6 | +2.70** | 0.001 | +3.04*** | 0.0003 |
| RELB | +1.74* | 0.017 | +2.14** | 0.001 |
| PRG4 | −47.62* | 0.023 | −49.61*** | 0.0006 |
| CD34 | −28.57* | 0.033 | −14.75** | 0.003 |
| IL-33 | −27.78* | 0.043 | −19.90*** | 0.0005 |
| MMP-10 | −20.06* | 0.018 | −16.54*** | 0.0003 |
| WISP2 | −15.15* | 0.027 | −8.78** | 0.009 |
| COL6A6 | −13.39* | 0.033 | −7.41*** | 0.0008 |
| IGFBP5 | −6.29* | 0.022 | −3.94** | 0.002 |
All mRNA values were normalised relative to that of GAPDH and triplicate experiments were performed for each gene. Statistically significant differences were expressed as *p < 0.05; **p < 0.01; ***p < 0.001.